Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -31.082% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) CCOC(=O)N1CCN(C(=O)c2cc(-c3ccc(OCC)cc3)nc3ccccc23)CC1
b) CCOC(=O)c1cccc(NC(=O)CCn2cccc2)c1
c) CC(=O)C1=C(O)C(=O)N(c2ccc(Br)cn2)C1c1cccc([N+](=O)[O-])c1
d) O=C(NCCC1=CCCCC1)C1CCCN(S(=O)(=O)c2cnc[nH]2)C1
e) COCCNC(=O)c1nc2ccccc2s1
Answer: a. CCOC(=O)N1CCN(C(=O)c2cc(-c3ccc(OCC)cc3)nc3ccccc23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)N1CCN(C(=O)c2cc(-c3ccc(OCC)cc3)nc3ccccc23)CC1
CCOC(=O)N1CCN(C(=O)c2cc(-c3ccc(OCC)cc3)nc3ccccc23)CC1
ethyl 4-[2-(4-ethoxyphenyl)quinoline-4-carbonyl]piperazine-1-carboxylate